ArticleBioactive materials2026
ADGRG1-targeted hypoxia preconditioned extracellular vesicles ameliorate intervertebral disc degeneration by delivering taurine to disrupt the oxidative stress feedback loop-driven ferroptosis in nucleus pulposus cells.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- UCHL3 drives ferroptosis in nucleus pulposus cells by deubiquitinating HMGB1 to activate NCOA4-mediated ferritinophagy.Autophagy · 2026Article
- ACSL4-Dependent Lysosomal Lipid Peroxidation Links WTAP-Mediated mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical spondylosis and low back pain caused by intervertebral disc degeneration (IVDD) are among the leading causes of clinical disability. Although excessive reactive oxygen species (ROS) are established drivers of IVDD, the mechanisms linking ROS accumulation to disc cell dysfunction, cell death programs, and disruption of intervertebral disc tissue homeostasis remain insufficiently elucidated, limiting the development of effective redox-targeted therapies. Here, we revealed the "ROS-Mitochondrial dysfunction-Ferritinophagy" oxidative stress feedback loop serves as the central mechanism driving ROS-induced nucleus pulposus cell (NPC) ferroptosis to promote IVDD progression. Furthermore, we identified the membrane protein ADGRG1 as a biomarker of ROS-induced ferroptosis in injured NPCs and developed ADGRG1-tethered peptide (A1TP)-modified hypoxia preconditioned extracellular vesicles (HX-EVs) with targeted antioxidant therapeutic potential. The engineered HX-EVs selectively accumulated in injured NPCs and delivered high levels of taurine, which bound to LKB1 (Glu165, Arg301) and MO25 (Arg194, Leu197) residues to facilitate the assembly of the LKB1-STRAD-MO25 kinase complex. This interaction regulated the expression of NCOA4 and TFAM by activating the AMPK/NRF2 signaling pathway, which suppressed ferritinophagy, enhanced mitochondrial repair and regeneration, and protected NPCs from ROS-induced ferroptosis, ultimately facilitating the repair of degenerated intervertebral discs. In summary, the A1TP-HX-EV system developed in this study provides a promising theranostic application for IVDD and offers valuable insights into the mechanisms of targeted HX-EV delivery and intervertebral disc regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.